(R)-CRZ and (S)-CRZ could ameliorate kidney ischemia-reperfusion injury in a mouse model [19], and they also eliminated lipid peroxides in CD8+ T cells to promote an anti-tumor effect, suggesting new therapeutic applications of (R)-CRZ and (S)-CRZ in treating ferroptosis-related diseases. The gene discussed is CD8A; the disease is neoplasm.